RAC 3.79% $1.53 race oncology ltd

Buyout/buyback strategies, page-3

  1. 890 Posts.
    lightbulb Created with Sketch. 469
    Do we know on what terms Shaws were approached though. I do get from their POV, a singular (or multiple) cross-trades are probably not great for them as they miss out on the brokerage fees that they gain when trickle selling.

    I dont see how @virtuozi's suggestion to include anticipated brokerage fees (and buyer fees) is not favourable to all parties. a XT is favourable to all parties but shaws.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.